Bacillus Calmette–Guérin (BCG) Vaccination and the Immune–Brain Axis: Implications for Neuroprotection and Neurodegenerative Disease
Magdalena Druszczynska, Beata Sadowska, Jakub Kulesza, Ewelina Kulesza, Marek Fol · 2026
Read Bacillus Calmette–Guérin (BCG) Vaccination and the Immune–Brain Axis: Implications for Neuroprotection and Neurodegenerative Disease by Magdalena Druszczynska, Beata Sadowska, Jakub Kulesza, Ewelina Kulesza, Marek Fol (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13211449.txt.
Description
Magdalena Druszczynska, Beata Sadowska, and their co-authors review links between the tuberculosis vaccine and brain health. Their 2026 review covers the BCG vaccine, made to prevent tuberculosis, which also retrains the innate immune system in lasting ways. That retraining changes how the body handles inflammation long after the shot.
Such immune shifts may reach the brain, where they can alter the activity of microglia, the brain's own immune cells, in pathways tied to diseases like Alzheimer's. Long infections such as tuberculosis, by contrast, keep inflammation simmering and may prime the brain toward damage. The review searched five major sources and preprint servers. It weighs the evidence that an old vaccine could protect the aging brain.
Catalog record
| CREATOR | Magdalena Druszczynska, Beata Sadowska, Jakub Kulesza, Ewelina Kulesza, Marek Fol |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |